Skip to main content
Staff Login
Username
*
Enter your The Contraceptive Pipeline Database username.
Password
*
Enter the password that accompanies your username.
Log in
Forgot password
Toggle navigation
BufferGel
Product Overview
Development Status:
Inactive
Target:
Female
Mode:
Non-hormonal
Delivery Type:
Vaginal Gel
Duration Type:
Short-acting
Description:
Spermicide gel
Updated date:
May 30, 2018
Vertical Tabs
Product Details
Active Pharmaceutical Ingredient (API):
Carbopol 974P
Potential Multi-Purpose Technology (MPT):
Yes
Regimen:
single
Duration:
single
Partner:
ReProtect Inc.
Status
Project Phase:
Late Development
Project Stage:
Phase III
Status Details:
Proven to be a safe, and effective contraceptive (in combination with diaphragm) in Phase III trials.
Programmatic Considerations
Considerations:
Intended to block HIV-infected cells, herpes, HPV, gonorrhea, and chlamydia in animal models, but failed to show efficacy in clinical trial.
Compatible with condoms and diaphragms.
Additional Information
Footnotes:
Polymers of acrylic acid cross-linked with polyalkenyl ethers or divinyl glycol
Download Product Report
